SLGL

Sol-Gel Technologies (SLGL)

About Sol-Gel Technologies (SLGL)

Sol-Gel Technologies Ltd. operates as a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. Its products include VERED, TWIN, and SIRS-T. The company was founded by David Avnir and Alon Seri-Levy on October 28, 1997 and is headquartered in Ness Ziona, Israel.

Details

Daily high

$65.78

Daily low

$63.38

Price at open

$64.20

52 Week High

$75.00

52 Week Low

$4.02

Market cap

183.2M

Dividend yield

0.00%

Volume

8,174

Avg. volume

26,023

P/E ratio

-20.39

Sol-Gel Technologies News